{Reference Type}: Journal Article
{Title}: Real-world evidence for oncological outcomes after radiotherapy or surgery for T1a-T1b glottic squamous cell carcinoma: A population-based cohort study.
{Author}: Viani GA;Moraes FY;Marta GN;Kowalski LP;Gouveia AG;
{Journal}: Head Neck
{Volume}: 45
{Issue}: 10
{Year}: 2023 10 9
{Factor}: 3.821
{DOI}: 10.1002/hed.27470
{Abstract}: Compare outcomes after surgery (S) or radiotherapy (RT) for T1a-T1b glottic squamous cell carcinoma (T1GSCC) in a population-based cohort study.<BR>Patients diagnosed with T1GSCC from 1999 to 2020 were identified from a public database. Clinical, demographic, and social data were extracted. Treatment and patient groups and subgroups were compared with log-rank test, Cox proportional test, and propensity-score matched (PSM).<BR>Eight hundred and eighty-eight patients with T1GSCC were included in the study, with a median follow-up of 61 months. The 5- and 10-year overall survival (OS) S versus RT were 76% versus 71% and 60% versus 52% (p = 0.02), respectively. In the subgroup analysis, S was associated with better OS for T1b, male, and public service patients (p < 0.05). In the PSM cohort of S versus RT with 110 patients each, there was no significant difference in the OS, CSS, and LC.<BR>T1GSCC has favorable outcomes with S or RT.